CDSCO Expert Committee Accepts Phase IV Safety Data for Eisai’s Lenvatinib Capsules
The Subject Expert Committee (SEC) under India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has accepted the Phase […]
EISAI-PHARMACEUTICALS-INDIA
